Ultrasonic Cavitation-Enabled Treatment for Therapy of Hypertrophic Cardiomyopathy: Proof of Principle

Ultrasound myocardial cavitation enabled treatment (MCET) was applied to the SS-16(BN) rat model of hypertrophic cardiomyopathy (HCM) for proof of the principle for myocardial reduction therapy. A focused ultrasound transducer was targeted using 10 MHz imaging (10S, GE Vivid 7) to the left ventricul...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ultrasound Med Biol
Egile Nagusiak: Miller, Douglas L., Lu, Xiaofang, Dou, Chunyan, Zhu, Yiying I., Fuller, Rachael, Fields, Kristina, Fabiilli, Mario L., Owens, Gabe E., Gordon, David, Kripfgans, Oliver D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5960614/
https://ncbi.nlm.nih.gov/pubmed/29681423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ultrasmedbio.2018.03.010
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak